دورية أكاديمية
Immunogenicity and efficacy of pembrolizumab and doxorubicin in a phase I trial for patients with metastatic triple-negative breast cancer
العنوان: | Immunogenicity and efficacy of pembrolizumab and doxorubicin in a phase I trial for patients with metastatic triple-negative breast cancer |
---|---|
المؤلفون: | Egelston, Colt A., Guo, Weihua, Yost, Susan E., Ge, Xuan, Lee, Jin Sun, Frankel, Paul H., Cui, Yujie, Ruel, Christopher, Schmolze, Daniel, Murga, Mireya, Tang, Aileen, Martinez, Norma, Karimi, Misagh, Somlo, George, Lee, Peter P., Waisman, James R., Yuan, YuanAff2, Aff5, IDs0026202303470y_cor17 |
المصدر: | Cancer Immunology, Immunotherapy. 72(9):3013-3027 |
قاعدة البيانات: | Springer Nature Journals |
تدمد: | 03407004 14320851 |
---|---|
DOI: | 10.1007/s00262-023-03470-y |